131 related articles for article (PubMed ID: 20102031)
21. Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment.
Bamias A; Terpos E; Dimopoulos MA
Onkologie; 2010; 33(6):288-9. PubMed ID: 20523090
[No Abstract] [Full Text] [Related]
22. Safety of denosumab in giant-cell tumour of bone.
Thomas D; Carriere P; Jacobs I
Lancet Oncol; 2010 Sep; 11(9):815. PubMed ID: 20816372
[No Abstract] [Full Text] [Related]
23. Rubber dam clamp trauma during endodontic treatment: a risk factor of bisphosphonate-related osteonecrosis of the jaw?
Gallego L; Junquera L; Pelaz A; Díaz-Bobes C
J Oral Maxillofac Surg; 2011 Jun; 69(6):e93-5. PubMed ID: 21211886
[No Abstract] [Full Text] [Related]
24. Osteonecrosis of the jaw and bevacizumab therapy.
Van Poznak C
Breast Cancer Res Treat; 2010 Jul; 122(1):189-91. PubMed ID: 20464477
[No Abstract] [Full Text] [Related]
25. Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment.
Wehrhan F; Hyckel P; Amann K; Ries J; Stockmann P; Schlegel K; Neukam F; Nkenke E
Oral Dis; 2011 May; 17(4):433-42. PubMed ID: 21366807
[TBL] [Abstract][Full Text] [Related]
26. Osteonecrosis of the jaws: what the physician needs to know: practical considerations.
Abughazaleh K; Kawar N
Dis Mon; 2011 Apr; 57(4):231-41. PubMed ID: 21569888
[No Abstract] [Full Text] [Related]
27. Osteonecrosis of the jaw in a patient on Denosumab.
Aghaloo TL; Felsenfeld AL; Tetradis S
J Oral Maxillofac Surg; 2010 May; 68(5):959-63. PubMed ID: 20149510
[No Abstract] [Full Text] [Related]
28. Safety and efficacy of denosumab in giant-cell tumour of bone.
Kyrgidis A; Toulis K
Lancet Oncol; 2010 Jun; 11(6):513-4. PubMed ID: 20522379
[No Abstract] [Full Text] [Related]
29. [Management of complications of bisphosphonates in oncology patients: jaw osteonecrosis].
Madrid C; Jaques B; Bouferrache K; Broome M
Rev Med Suisse; 2007 May; 3(112):1322, 1324-6, 1329-31. PubMed ID: 17596069
[TBL] [Abstract][Full Text] [Related]
30. Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a review.
Almazrooa SA; Woo SB
J Am Dent Assoc; 2009 Jul; 140(7):864-75. PubMed ID: 19571050
[TBL] [Abstract][Full Text] [Related]
31. Bisphosphonate-related osteonecrosis of the jaw associated with dental implants.
Lazarovici TS; Yahalom R; Taicher S; Schwartz-Arad D; Peleg O; Yarom N
J Oral Maxillofac Surg; 2010 Apr; 68(4):790-6. PubMed ID: 20307764
[TBL] [Abstract][Full Text] [Related]
32. The role of dental hygienist in the prevention of osteonecrosis of the jaw in patients wearing dentures.
Kyrgidis A; Teleioudis Z; Vahtsevanos K
Int J Dent Hyg; 2010 May; 8(2):154. PubMed ID: 20522142
[No Abstract] [Full Text] [Related]
33. Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw.
Compston J
Osteoporos Int; 2011 Dec; 22(12):2951-61. PubMed ID: 21997225
[TBL] [Abstract][Full Text] [Related]
34. The phenomenon of osteonecrosis of the jaw in patients with metastatic breast cancer.
Van Poznak C
Cancer Invest; 2006 Feb; 24(1):110-2. PubMed ID: 16467002
[TBL] [Abstract][Full Text] [Related]
35. A current update on osteonecrosis of the jaw and bisphosphonates.
Arrain Y; Masud T
Dent Update; 2011 Dec; 38(10):672-6, 678. PubMed ID: 22408887
[TBL] [Abstract][Full Text] [Related]
36. Rubber dam clamp trauma, root canal therapy, and osteonecrosis of the jaw.
Kyrgidis A; Arora A; Antoniades K
J Oral Maxillofac Surg; 2011 Jul; 69(7):1854-5; author reply 1855-6. PubMed ID: 21684445
[No Abstract] [Full Text] [Related]
37. Antiresorptives and osteonecrosis of the jaw.
Yamashita J; McCauley LK
J Evid Based Dent Pract; 2012 Sep; 12(3 Suppl):233-47. PubMed ID: 23040351
[TBL] [Abstract][Full Text] [Related]
38. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonate-associated osteonecrosis of the jaws after surgery? Part II: a prospective clinical study.
Lee CY; Suzuki JB
Implant Dent; 2010 Feb; 19(1):29-38. PubMed ID: 20147814
[TBL] [Abstract][Full Text] [Related]
39. "Fatigue" having a role in the pathogenesis of osteonecrosis of the jaws.
Kyrgidis A; Vahtsevanos K
Clin Oral Investig; 2009 Dec; 13(4):479-80; author reply 483-4. PubMed ID: 19680698
[No Abstract] [Full Text] [Related]
40. Bisphosphonates and osteonecrosis of the jaw.
Sambrook P; Olver I; Goss A
Aust Fam Physician; 2006 Oct; 35(10):801-3. PubMed ID: 17019456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
